Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 35

1.

Risk of radiation-induced malignancy with heterotopic ossification prophylaxis: a case-control analysis.

Sheybani A, TenNapel MJ, Lack WD, Clerkin P, Hyer DE, Sun W, Jacobson GM.

Int J Radiat Oncol Biol Phys. 2014 Jul 1;89(3):584-9. doi: 10.1016/j.ijrobp.2014.03.008. Epub 2014 May 3.

PMID:
24803038
2.

Cancer risk estimates from radiation therapy for heterotopic ossification prophylaxis after total hip arthroplasty.

Mazonakis M, Berris T, Lyraraki E, Damilakis J.

Med Phys. 2013 Oct;40(10):101702. doi: 10.1118/1.4820366.

PMID:
24089892
3.

Low rates of heterotopic ossification after resurfacing hip arthroplasty with use of prophylactic radiotherapy in select patients.

Kruser TJ, Kozak KR, Cannon DM, Platta CS, Heiner JP, Illgen RL 2nd.

J Arthroplasty. 2012 Aug;27(7):1349-53. doi: 10.1016/j.arth.2011.11.017. Epub 2012 Jan 14.

4.

Incidence of heterotopic ossification and effects of various prophylactic methods after hip resurfacing.

Le Duff MJ, Takamura KB, Amstutz HC.

Bull NYU Hosp Jt Dis. 2011;69 Suppl 1:S36-41.

5.

[Heterotopic ossifications in total hip arthroplasty: prophylaxis and therapy].

Schauwecker J, Pohlig F, Toepfer A, Gollwitzer H, von Eisenhart-Rothe R.

Orthopade. 2011 Jun;40(6):500-5. doi: 10.1007/s00132-011-1759-9. German.

PMID:
21584735
6.

The role of radiation dose in a combined therapeutic protocol for the prevention of heterotopic ossification after total hip replacement.

Pakos EE, Tsekeris PG, Paschos NK, Pitouli EJ, Motsis EK, Xenakis TA.

J BUON. 2010 Jan-Mar;15(1):74-8.

PMID:
20414931
7.

Combined radiotherapy and indomethacin for the prevention of heterotopic ossification after total hip arthroplasty.

Pakos EE, Stafilas KS, Tsekeris PG, Politis AN, Mitsionis G, Xenakis TA.

Strahlenther Onkol. 2009 Aug;185(8):500-5. doi: 10.1007/s00066-009-1954-3. Epub 2009 Aug 4.

PMID:
19652932
8.

Heterotopic ossification after total hip arthroplasty (THA) in congenital hip disease: comparison of two different prophylactic protocols.

Pakos EE, Stafilas KS, Politis AN, Tsekeris PG, Mitsionis G, Xenakis TA.

Clin Transl Oncol. 2009 Feb;11(2):103-8.

PMID:
19211376
9.

Prophylaxis of heterotopic ossification in patients sedated after polytrauma : medical and ethical considerations.

Oertel S, Schneider U, Keel M, Lütolf UM, Bosshard G.

Strahlenther Onkol. 2008 Apr;184(4):212-7. doi: 10.1007/s00066-008-1757-y.

PMID:
18398586
10.

Cost of radiotherapy versus NSAID administration for prevention of heterotopic ossification after total hip arthroplasty.

Strauss JB, Chen SS, Shah AP, Coon AB, Dickler A.

Int J Radiat Oncol Biol Phys. 2008 Aug 1;71(5):1460-4. doi: 10.1016/j.ijrobp.2007.12.006. Epub 2008 Jan 30.

PMID:
18234435
11.

Heterotopic ossification in patients after total hip replacement.

Stołtny T, Koczy B, Wawrzynek W, Miszczyk L.

Ortop Traumatol Rehabil. 2007 May-Jun;9(3):264-72. Review. English, Polish.

PMID:
17721424
12.

Shielding of the hip prosthesis during radiation therapy for heterotopic ossification is associated with increased failure of prophylaxis.

Balboni TA, Gaccione P, Gobezie R, Mamon HJ.

Int J Radiat Oncol Biol Phys. 2007 Apr 1;67(5):1499-505. Epub 2007 Jan 17.

PMID:
17234358
13.

The influence of heterotopic ossification on functional status of hip joint following total hip arthroplasty.

Pohl F, Seufert J, Tauscher A, Lehmann H, Springorum HW, Flentje M, Koelbl O.

Strahlenther Onkol. 2005 Aug;181(8):529-33.

PMID:
16044221
14.

Prophylaxis of heterotopic bone formation by radiotherapy -- a comparison between pre- and postsurgical activity.

Roth A, Füller J, Fährmann M, Anders J, Sachse A, Sander K, Venbrocks R.

Acta Chir Orthop Traumatol Cech. 2005;72(1):38-41.

PMID:
15860151
15.

Optimal timing of preoperative radiation for prophylaxis against heterotopic ossification. A rabbit hip model.

Rumi MN, Deol GS, Bergandi JA, Singapuri KP, Pellegrini VD Jr.

J Bone Joint Surg Am. 2005 Feb;87(2):366-73.

PMID:
15687161
16.

[Prevention of heterotopic ossification following prosthetic total hip replacement].

Zouhair A, Ozsahin M, Garofalo R, Leyvraz PF, Theumann N, Mirimanoff RO, Coucke PA, Mouhsine E.

Rev Med Suisse Romande. 2004 Sep;124(9):579-82. Review. French.

PMID:
15552755
18.

[Radiotherapy as prevention of heterotopic ossification--preliminary results].

Miszczyk L, Spindel J, Maciejewski B, Walichiewicz P, Tarnawski R, Horzela A, Woźniak G.

Przegl Lek. 2004;61(2):61-4. Polish.

PMID:
15230142
19.

Preoperative irradiation for prevention of heterotopic ossification following prosthetic total hip replacement results of a prospective study in 462 hips.

Koelbl O, Seufert J, Pohl F, Tauscher A, Lehmann H, Springorum HW, Flentje M.

Strahlenther Onkol. 2003 Nov;179(11):767-73.

PMID:
14605747
20.

Prevention of heterotopic ossification after total hip replacement with NSAIDs.

Fijn R, Koorevaar RT, Brouwers JR.

Pharm World Sci. 2003 Aug;25(4):138-45. Review.

PMID:
12964491
Items per page

Supplemental Content

Loading ...
Write to the Help Desk